Conditional Survival After HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial
Journal of Cardiac Failure · 2023
DOI: 10.1016/j.cardfail.2023.06.012 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Cardiac Failure, 2023. Verfasst von Isabel C Balachandran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Texas Heart Institute, Houston, TX. Hauptthemen laut MEDLINE: Heart Failure, Heart-Assist Devices. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, The Texas Heart Institute, Houston, TX.
- Department of Cardiology, The Texas Heart Institute, Houston, TX.. Electronic address: Jrogers@texasheart.org.
Zitieren
APA
Balachandran, I. C., Segar, M. W., Diakos, N. A., & Rogers, J. G. (2023). Conditional Survival After HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2023.06.012
Vancouver
Balachandran IC, Segar MW, Diakos NA, Rogers JG. Conditional Survival After HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial. Journal of Cardiac Failure. 2023. doi:10.1016/j.cardfail.2023.06.012
BibTeX
@article{Balachandran2023,
author = {Balachandran, Isabel C and Segar, Matthew W and Diakos, Nikolaos A and Rogers, Joseph G},
title = {Conditional Survival After HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial},
journal = {Journal of Cardiac Failure},
year = {2023},
doi = {10.1016/j.cardfail.2023.06.012}
}
EUVIMED